We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Non-Hormonal Comparison · All 50 States
Non-hormonal menopause treatments compared: fezolinetant, low-dose paroxetine, venlafaxine, gabapentin, oxybutynin, CBT and clinical hypnosis — effectiveness, side effects, and who each suits.
Start your visit — $79/mo →← Hormone replacement therapy pillar
DIRECT ANSWER
When hormone therapy is contraindicated or unwanted, the options with the strongest evidence for hot flashes are fezolinetant (an NK3 receptor antagonist), low-dose paroxetine (the only FDA-approved non-hormonal drug for vasomotor symptoms until fezolinetant), venlafaxine or escitalopram, gabapentin for night-time symptoms, and cognitive behavioral therapy or clinical hypnosis. Non-hormonal options typically reduce hot flashes by 40–65 percent, compared with 75–90 percent for systemic estrogen.
| Option | Class | Typical dose | Best suited to | Trade-off |
|---|---|---|---|---|
| Fezolinetant | NK3 receptor antagonist | 45 mg daily | Moderate-to-severe hot flashes with a hormone contraindication | Liver monitoring required; newer, costlier, coverage varies |
| Low-dose paroxetine mesylate | SSRI (FDA-approved for VMS) | 7.5 mg nightly | Hot flashes plus sleep disruption | Do not combine with tamoxifen (CYP2D6 inhibition) |
| Venlafaxine or escitalopram | SNRI / SSRI (off-label) | 37.5–150 mg; 10–20 mg | Coexisting mood symptoms | Nausea, sexual side effects, discontinuation symptoms |
| Gabapentin | Anticonvulsant (off-label) | 300–900 mg at bedtime | Night sweats and sleep-onset difficulty | Sedation, dizziness; daytime dosing poorly tolerated |
| CBT or clinical hypnosis | Behavioral | 4–8 structured sessions | Bother and sleep impact; anyone avoiding medication | Reduces distress and interference more than flush frequency; access varies |
| Oxybutynin | Anticholinergic (off-label) | 2.5–5 mg twice daily | Refractory vasomotor symptoms | Dry mouth; anticholinergic burden concerns with long-term use |
Doses shown are typical starting ranges for context only. Your clinician sets your dose based on your history.
Fezolinetant and low-dose paroxetine have the strongest regulatory and trial support. Both reduce hot flash frequency and severity meaningfully, though less than systemic estradiol.
Most do not outperform placebo in randomized trials, including black cohosh, evening primrose oil, and red clover. Placebo response in menopause trials is high, which is why uncontrolled testimonials are misleading.
Frequently yes. Vaginal estrogen has minimal systemic absorption and treats a different problem — genitourinary symptoms — than the systemic vasomotor treatments listed here.
Not automatically. Every option here carries its own side-effect and monitoring profile. For most healthy women within 10 years of menopause, guideline bodies conclude the benefits of hormone therapy outweigh its risks.
A board-certified clinician licensed in your state reviews your intake within one business day and recommends the route that fits your history — not a template.
Start your visit — $79/mo →Comparing providers first? How to choose an HRT telehealth provider →
WRITTEN & MEDICALLY REVIEWED BY
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.
Organizational NPI 1609792902 · Last reviewed July 3, 2026 · Editorial policy
Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.
SOURCES & REFERENCES
Information on this page is for educational purposes only. Prescription medications require clinical evaluation and provider approval. Individual results vary. Not an emergency service.